These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34843394)

  • 1. NAD
    Abdellatif M; Sedej S; Kroemer G
    Circulation; 2021 Nov; 144(22):1795-1817. PubMed ID: 34843394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy.
    Diguet N; Trammell SAJ; Tannous C; Deloux R; Piquereau J; Mougenot N; Gouge A; Gressette M; Manoury B; Blanc J; Breton M; Decaux JF; Lavery GG; Baczkó I; Zoll J; Garnier A; Li Z; Brenner C; Mericskay M
    Circulation; 2018 May; 137(21):2256-2273. PubMed ID: 29217642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns.
    Bhasin S; Seals D; Migaud M; Musi N; Baur JA
    Endocr Rev; 2023 Nov; 44(6):1047-1073. PubMed ID: 37364580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging potential benefits of modulating NAD
    Matasic DS; Brenner C; London B
    Am J Physiol Heart Circ Physiol; 2018 Apr; 314(4):H839-H852. PubMed ID: 29351465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAD+ metabolism and therapeutic strategies in cardiovascular diseases.
    Shi C; Wen Z; Yang Y; Shi L; Liu D
    Atheroscler Plus; 2024 Sep; 57():1-12. PubMed ID: 38974325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD in pathological cardiac remodeling: Metabolic regulation and beyond.
    Norambuena-Soto I; Deng Y; Brenner C; Lavandero S; Wang ZV
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167038. PubMed ID: 38281710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide Adenine Dinucleotide in the Development and Treatment of Cardiac Remodeling and Aging.
    Pei Z; Wang F; Wang K; Wang L
    Mini Rev Med Chem; 2022; 22(18):2310-2317. PubMed ID: 35249481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-targeted Effect of Nicotinamide Mononucleotide on Brain Bioenergetic Metabolism.
    Klimova N; Kristian T
    Neurochem Res; 2019 Oct; 44(10):2280-2287. PubMed ID: 30661231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide adenine dinucleotide: Biosynthesis, consumption and therapeutic role in cardiac diseases.
    Tannous C; Booz GW; Altara R; Muhieddine DH; Mericskay M; Refaat MM; Zouein FA
    Acta Physiol (Oxf); 2021 Mar; 231(3):e13551. PubMed ID: 32853469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target.
    Griffiths HBS; Williams C; King SJ; Allison SJ
    Biochem Soc Trans; 2020 Jun; 48(3):733-744. PubMed ID: 32573651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of NAD
    Chu X; Raju RP
    Metabolism; 2022 Jan; 126():154923. PubMed ID: 34743990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinamide adenine dinucleotide homeostasis and signalling in heart disease: Pathophysiological implications and therapeutic potential.
    Mericskay M
    Arch Cardiovasc Dis; 2016 Mar; 109(3):207-15. PubMed ID: 26707577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinamide adenine dinucleotide emerges as a therapeutic target in aging and ischemic conditions.
    Hosseini L; Vafaee MS; Mahmoudi J; Badalzadeh R
    Biogerontology; 2019 Aug; 20(4):381-395. PubMed ID: 30838484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirtuins and NAD
    Kane AE; Sinclair DA
    Circ Res; 2018 Sep; 123(7):868-885. PubMed ID: 30355082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-203 improves cardiac dysfunction by targeting PARP1-NAD
    Zhao L; Tang P; Lin Y; Du M; Li H; Jiang L; Xu H; Sun H; Han J; Sun Z; Xu R; Lou H; Chen Z; Kopylov P; Liu X; Zhang Y
    Aging Cell; 2024 Mar; 23(3):e14063. PubMed ID: 38098220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD+ and sirtuins in aging and disease.
    Imai S; Guarente L
    Trends Cell Biol; 2014 Aug; 24(8):464-71. PubMed ID: 24786309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs Targeting Mechanisms of Aging to Delay Age-Related Disease and Promote Healthspan: Proceedings of a National Institute on Aging Workshop.
    Espinoza SE; Khosla S; Baur JA; de Cabo R; Musi N
    J Gerontol A Biol Sci Med Sci; 2023 Jun; 78(Suppl 1):53-60. PubMed ID: 37325957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD metabolism: Implications in aging and longevity.
    Yaku K; Okabe K; Nakagawa T
    Ageing Res Rev; 2018 Nov; 47():1-17. PubMed ID: 29883761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the histidine triad nucleotide-binding protein 2 protects cardiac function in the adult mice after acute myocardial infarction.
    Fan M; Chen Z; Huang Y; Xia Y; Chen A; Lu D; Wu Y; Zhang N; Zhang P; Li S; Chen J; Zhang Y; Sun A; Zou Y; Hu K; Qian J; Ge J
    Acta Physiol (Oxf); 2020 Apr; 228(4):e13439. PubMed ID: 31900976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.